Su XP. et al.
NSD1 inactivation and SETD2 mutation drive a convergence toward loss of function of H3K36 writers in Clear Cell Renal Cell Carcinomas.
Cancer Res. (2017) Sept. 77 (18): 4835-4845
doi: 10.1158/0008-5472.CAN-17-0143
Su XP. et al.
NSD1 inactivation and SETD2 mutation drive a convergence toward loss of function of H3K36 writers in Clear Cell Renal Cell Carcinomas.
Cancer Res. (2017) Sept. 77 (18): 4835-4845
doi: 10.1158/0008-5472.CAN-17-0143